Join
Live feed
·
INSIDERFilingvia Quantisnow
TG Therapeutics Inc. logo

SEC Form 4: Echelard Yann bought $95,760 worth of shares (9,000 units at $10.64), increasing direct ownership by 5% to 201,848 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TGTX (TG Therapeutics Inc.) and more on Quantisnow.